COLLEAGUE Infusion Pump

April 28, 2006 – The COLLEAGUE Volumetric Infusion Pump manufactured by Baxter Healthcare Corporation was recalled in July 2005. There was also an urgent correction in December 2005 (with an update in February 2006). The FDA is now recommending that healthcare providers take additional “important safety steps” when using the Baxter infusion pumps. The risks involved in using the Baxter infusion pump are great. Patients have died while the Baxter Volumetric Infusion Pump was in use. If you or someone you love has suffered injury due to the use of a Baxter Healthcare COLLEAGUE Volumetric Infusion Pump, a lawyer at PritzkerOlsen, P.A., a premier national law firm, is available for a free consultation. You can reach a lawyer at our law firm by calling toll-free at 1-888-377-8900 or filling out our online consultation form.

Senior partner Fred Pritzker has more than 30 years of experience and focuses his practice on complex product liability cases. He is currently lead attorney in a major product liability case involving victims from several states. In recognition of his achievements, other lawyers have selected him for inclusion in the current edition of The Best Lawyers in America.

Below are the July 2005 FDA recall announcement and updates regarding the Baxter Healthcare COLLEAGUE Volumetrtic Infusion Pump.

June 29, 2006 (Updated information) – According to a story in the Chicago Tribune, Baxter International Inc. settled a suit filed by the FDA in October 2005 on June 29, 2006. Baxter agreed to stop manufacturing and distributing the Colleague Volumetric Infusion Pump and the Syndeo PCA Syringe Pump until the Baxter fixes defects alleged by the FDA that appear to have caused some of the devices to stop operating, resulting in 8 deaths and 16 serious injuries. Source: Bruce Japsen, “Baxter settles medical pumps suit,” Chicago Tribune, June 29, 2006. Read the FDA news release regarding the Colleague infusion pump and the Syndeo pump.

December 13, 2005 and February 3, 2006 (Updated Recall Information) --The Baxter Infusion Pump recall below was updated to reflect additional problems with the pump, including the following:

Battery Undercharging: The pump’s battery charge level indicator may overstate the battery power level and shut down when operating on battery power if not charged for a full 12 hours following a “low battery” alarm.
False Air Detection Alarms: If the pump’s tubing is stretched or pulled, the pump’s sensors may misinterpret this tension as air in the line, resulting in a false alarm and shutting down the pump.
Gearbox Wear: Worn parts in the pump’s motor can cause the pump to shut down and interrupt therapy.
Under-infusion: If there is an obstruction during tube-loading, the upper jaw of the pump head can be moved out of alignment, resulting in insufficient fluid delivery.
Non-detection of upstream occlusion: Improperly spiked bags, use of a source container which has had all air removed, improper venting of the container, and an unopened air vent above the burette chamber may result in the pump not detecting an upstream occlusion.

Any of these failures may delay or interrupt therapy, which could result in a life-threatening situation for patients, depending on the type of therapy being administered. The FDA has provided additional information in a February 3, 2006, announcement.

Baxter Healthcare COLLEAGUE Infusion Pump Recall
July 21, 2005--The U.S. Food and Drug Administration (FDA) is announcing that Baxter Healthcare Corporation of Deerfield, Ill., has initiated a worldwide recall of all models of its Colleague Volumetric Infusion Pumps because they can shut down while delivering critical medication and fluids to patients. Baxter has received six reports of serious injury and three reports of death associated with this shut-down problem. The affected are: Models 2M8151, 2M8151R, 2M8161, 2M8161R, 2M8153, 2M8153R, 2M8163, and 2M8163R.

Based on information from a current FDA inspection and independent analysis of the failure modes by FDA's Office of Science and Engineering Laboratories, as well as a comprehensive review of adverse event reports in FDA's database, FDA has determined that this action is a Class I recall. Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the affected product will cause serious injury or death.

"Given the widespread use of these pumps and the multiple failure modes, FDA is quickly informing users of this important safety issue," said Daniel Schultz, M.D., Director of FDA's Center for Devices and Radiological Health. "We will continue to monitor the situation closely and inform the public immediately of any new developments."

The firm notified customers today that it has voluntarily stopped shipping Colleague Volumetric Infusion Pumps until the problems are resolved. Baxter also advised customers on March 15, 2005, to stop using any pumps that exhibit a failure code beginning with 402, 403, 533, 535, or 599, related to these electronic problems. Additionally, Baxter advised customers to take out of service any pumps that exhibit failure codes 810:04 and 810:11 related to air-in-line sensor problems, until they are inspected by authorized service personnel.

In addition to the shut-down problem, the device may exhibit two additional failure modes:

Users may inadvertently press the on/off key instead of the start key when attempting to start an infusion.
Disconnecting or connecting the pump from the hospital monitoring system while the pump is powered "on" can result in a failure code, requiring the infusion to be restarted.

Also, these failures may occur during the infusion of therapy, so it is imperative that health care institutions have a contingency plan to mitigate any disruptions of infusions of life-sustaining drugs or fluids.

Approximately 255,000 Colleague Volumetric Infusion Pumps are currently in use, including 206,000 distributed in the United States. They have been sold to physicians, hospitals, pharmacies, and a variety of other medical facilities.

At this time, users should not return the pumps to Baxter.

Baxter's letters to customers are available on its web site at www.Baxter.com. (*Note: Do not contact the company before consulting a product liability lawyer.) Consumers who have questions about the recall may contact Baxter Healthcare at 1-800-422-9837. Those who have technical questions may contact Baxter Healthcare at 1-800-THE-PUMP (800-843-7867).

If you are a physician or a patient who has experienced a problem with any of these infusion pumps, please send a report to FDA's MedWatch program and to Baxter. See http://www.fda.gov/medwatch/ for filing information or call 1-800-FDA-1088 (1-800-332-1088).

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01209.html

Free Case Consultation

We are Not Paid Unless You Win

Our attorneys work on a continguency fee basis, meaning you do not have to pay our law firm for representing you unless we win you money.

Firm News

AV Preeminent Rating by Martindale-Hubbell

Attorneys Fred Pritzker and Eric Hageman have been given the highest rating by Martindale-Hubbell for attorney, AV Preeminent. An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence.

Adjunct Teaching Position At U of M Law School

Attorney Brendan Flaherty has accepted an adjunct teaching position at the University of Minnesota Law School. For the 2011 spring semester, Flaherty will teach a course entitled "Practice and Professionalism," which will introduce students to foundational lawyering skills and professional responsibility issues.

Attorney Elliot Olsen Speaks at Conference

Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation. He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific.

Named Super Lawyer

In recognition of their achievements, Attorneys Fred Pritzker, Elliot Olsen and Eric Hageman were named "Super Lawyers" by Law & Politics magazine. According to Super Lawyers, "The objective is to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource to assist attorneys and consumers in the search for legal counsel."

Brendan Flaherty Named a Rising Star

In recognition of his achievements, Attorney Brendan Flaherty was named a 2010 Rising Star by Minnesota Law & Politics. Only 2.5 percent of the state’s lawyers are included on the list, which highlights Minnesota’s best up-and-coming legal talent.

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

This is attorney advertising. Past results do not guarantee a similar outcome. The result of each case is determined by the specific facts and the applicable law.